Haemophilia A with inhibitors
Clinical trials for Haemophilia A with inhibitors explained in plain language.
Never miss a new study
Get alerted when new Haemophilia A with inhibitors trials appear
Sign up with your email to follow new studies for Haemophilia A with inhibitors, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New drug Mim8 shows promise for Long-Term bleeding prevention in hemophilia a
Disease control OngoingThis study tests Mim8, a drug that helps blood clot by mimicking a missing protein, in people with hemophilia A (with or without inhibitors). Over 450 participants will receive injections for up to 5.5 years to see if it safely prevents bleeding episodes. The goal is to provide a…
Matched conditions: HAEMOPHILIA A WITH INHIBITORS
Phase 3 • Sponsor: Novo Nordisk A/S • Aim: Disease control
Last updated Sep 11, 2026 00:00 UTC
-
New daily injection could cut bleeding in Tough-to-Treat hemophilia
Disease control OngoingThis study tests a drug called concizumab, given as a daily shot under the skin, to prevent bleeding in people with hemophilia A or B who have inhibitors (antibodies that block standard treatment). About 134 participants either start concizumab right away or continue their usual …
Matched conditions: HAEMOPHILIA A WITH INHIBITORS
Phase 3 • Sponsor: Novo Nordisk A/S • Aim: Disease control
Last updated Sep 11, 2026 00:00 UTC